Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRR3 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | CREG1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | SF3B2 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | CDS1 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
mRNA | RXRG | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
mRNA | APOD | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | ADSS | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | PRSS8 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
mRNA | CENPT | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |